why choose us

First received: July 08, 2024

Clinical Trial: A Study to Evaluate Skin and Plasma Pharmacokinetic of Multiple Doses of Povorcitinib After Oral Administration in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Skin and Plasma Pharmacokinetic Study of Multiple Doses of Povorcitinib After Oral Administration in Healthy Participants

Brief Summary: The purpose of this study is to measure the effect of multiple doses of orally administered povorcitinib on skin PK and to characterize plasma PK parameters of povorcitinib following multiple doses of orally administered povorcitinib.inhealthy participants.

Read more